Tolerability of ORM-12741 and effects on episodic memory in patients with Alzheimer's disease

INTRODUCTION: ORM-12741 is a novel selective antagonist of alpha-2C adrenoceptors. This trial evaluated the safety and efficacy of ORM-12741 in patients with Alzheimer's disease (AD). METHODS: A randomized, double-blind, placebo-controlled, exploratory phase 2a trial was conducted in 100 subjec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Dement (N Y)
Main Authors: Rinne, Juha O., Wesnes, Keith, Cummings, Jeffrey L., Hakulinen, Pasi, Hallikainen, Merja, Hänninen, Jutta, Murphy, Michael, Riordan, Henry, Scheinin, Mika, Soininen, Hilkka, Rouru, Juha
Formato: Artigo
Idioma:Inglês
Publicado em: Elsevier 2016
Assuntos:
Featured Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5651366/
https://ncbi.nlm.nih.gov/pubmed/29067315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trci.2016.11.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados